Android Apple

Here's Why Arcellx (ACLX) Slipped in Q2

By Yahoo! Finance   |   4 months ago
Here's Why Arcellx (ACLX) Slipped in Q2

Baron Funds' "Baron Health Care Fund" Q2 2024 investor letter reported a 2.55% decline compared to benchmarks. The fund highlighted Arcellx, Inc. (NASDAQ:ACLX) as a top pick, with significant growth potential in cell therapies.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.